Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Valvular Heart Disease

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 382 articles: HTML format

Single Articles

September 2024
1. DWECK MR, Craig NJ
   Medical Therapy for Aortic Stenosis: Abandon Ship or Full Steam Ahead?
   J Am Coll Cardiol. 2024;84:1076-1077.
   PubMed    
   
   
   
2. SONG JK, Lee S, Kim YJ, Kim HK, et al
   Effect of Evogliptin on the Progression of Aortic Valvular Calcification.
   J Am Coll Cardiol. 2024;84:1064-1075.
   PubMed     Abstract available
   
   
   
3. DESAI MY, Owens A, Wolski K, Geske JB, et al
   Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial.
   J Am Coll Cardiol. 2024;84:1041-1045.
   PubMed    
   
   
   August 2024
4. PONIKOWSKI P, Friede T, von Bardeleben RS, Butler J, et al
   Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2.
   J Am Coll Cardiol. 2024 Aug 30:S0735-1097(24)08233.
   PubMed     Abstract available
   
   
   
5. ANKER MS, Porthun J, Schulze PC, Rassaf T, et al
   Percutaneous Transcatheter Edge-To-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-Analysis of 3 Randomized Controlled Trials.
   J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08231.
   PubMed    
   
   
   
6. IVANAUSKIENE T, Zuoziene G, Zakarkaite D, Tarutis V, et al
   The Anterior Mitral Valve Leaflet Prolapse as a Key to Diagnosis of ALCAPA Syndrome.
   J Am Coll Cardiol. 2024;84:868-873.
   PubMed     Abstract available
   
   
   
7. HAHN RT, Lindenfeld J, Lim SD, Mack MJ, et al
   Structural Cardiac Interventions in Patients With Heart Failure: JACC Scientific Statement.
   J Am Coll Cardiol. 2024;84:832-847.
   PubMed     Abstract available
   
   
   
8. ADRICHEM R, Rodes Cabau J, Mehran R, Park DW, et al
   Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week.
   J Am Coll Cardiol. 2024;84:848-861.
   PubMed     Abstract available
   
   
   
9. JORDE UP, Benza R, McCarthy PM, Ailawadi G, et al
   Impact of Renal & Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair.
   J Am Coll Cardiol. 2024 Aug 23:S0735-1097(24)08275.
   PubMed     Abstract available
   
   
   
10. HINKOV H, Greve D, Lee CB, Klein C, et al
    Combined Surgical and Percutaneous Management of Circumflex Artery Occlusion After Minimally Invasive Mitral Valve Repair.
    J Am Coll Cardiol. 2024;84:766-770.
    PubMed     Abstract available
    
    
    
11. LANSKY AJ, Grubman D, Dwyer MG 3rd, Zivadinov R, et al
    Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR: Results of a Patient-Level Pooled Analysis.
    J Am Coll Cardiol. 2024;84:712-722.
    PubMed     Abstract available
    
    
    
12. PAPAPOSTOLOU S, Kearns J, Costello BT, O'Brien J, et al
    Comparison of Pressure vs Volume Overload Ventricular Wall Stress in Patients With Valvular Heart Disease.
    J Am Coll Cardiol. 2024;84:635-644.
    PubMed     Abstract available
    
    
    
13. SORAJJA P, Hamid N
    A Bright Future for Tricuspid Repair Success.
    J Am Coll Cardiol. 2024;84:617-619.
    PubMed    
    
    
    
14. LURZ P, Rommel KP, Schmitz T, Bekeredjian R, et al
    Real-World 1-Year Results of Tricuspid Edge-to-Edge Repair From the bRIGHT Study.
    J Am Coll Cardiol. 2024;84:607-616.
    PubMed     Abstract available
    
    
    
15. YANG TY, Small AM, Dufresne L, Peloso GM, et al
    Plasma Proteomic Biomarkers of Aortic Stenosis: A Mendelian Randomization Study.
    J Am Coll Cardiol. 2024;84:592-594.
    PubMed    
    
    
    
16. HUSAINI M, Bach RG, Cresci S
    Exercise Testing to Unmask Latent LVOT Obstruction in a Highly Symptomatic Patient With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;84:602-606.
    PubMed     Abstract available
    
    
    July 2024
17. CARRILLO MORA LM, Tercero Fajardo JJ, Cruz Sepulveda DM, Gimeno Blanes JR, et al
    Septal Ablation to Treat Subaortic Dynamic Obstruction Following Transcatheter Aortic Valve Implantation.
    J Am Coll Cardiol. 2024;84:411-415.
    PubMed     Abstract available
    
    
    
18. SPADACCIO C, Nenna A, Pisani A, Laskawski G, et al
    Sutureless Valves, a "Wireless" Option for Patients With Aortic Valve Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:382-407.
    PubMed     Abstract available
    
    
    
19. CASPER MR, Cohen G, Stripe B
    Sustained Intraprocedural Cardiac Arrest During BASILICA TAVR.
    J Am Coll Cardiol. 2024;84:317-321.
    PubMed     Abstract available
    
    
    
20. HAHN RT, Lindenfeld J, Bohm M, Edelmann F, et al
    Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:195-212.
    PubMed     Abstract available
    
    
    June 2024
21. COYLEWRIGHT M, Cibotti-Sun M, Moore MM
    2024 Hypertrophic Cardiomyopathy Guideline-at-a-Glance.
    J Am Coll Cardiol. 2024;83:2406-2410.
    PubMed    
    
    
    
22. OMMEN SR, Ho CY, Asif IM, Balaji S, et al
    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2024;83:2324-2405.
    PubMed     Abstract available
    
    
    May 2024
23. AMBARDEKAR AV, Kopecky BJ, Raymer DS
    Finding an Unobstructed View Toward the Treatment of Nonobstructive Hypertrophic Cardiomyopathy: Lifting the Hunger Fog.
    J Am Coll Cardiol. 2024;83:2049-2051.
    PubMed    
    
    
    
24. MARON MS, Mahmod M, Abd Samat AH, Choudhury L, et al
    Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:2037-2048.
    PubMed     Abstract available
    
    
    
25. HAHN RT, Wilkoff BL, Kodali S, Birgersdotter-Green UM, et al
    Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:2002-2014.
    PubMed     Abstract available
    
    
    
26. ESTEVEZ-LOUREIRO R, Lorusso R, Taramasso M, Torregrossa G, et al
    Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5.
    J Am Coll Cardiol. 2024;83:1799-1817.
    PubMed     Abstract available
    
    
    April 2024
27. ATLURI P, Iyengar A, Rekhtman D
    Risks and Benefits of Concomitant Tricuspid Surgery at the Time of Mitral Intervention.
    J Am Coll Cardiol. 2024;83:1669-1670.
    PubMed    
    
    
    
28. IRIBARNE A, Alabbadi SH, Moskowitz AJ, Ailawadi G, et al
    Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery.
    J Am Coll Cardiol. 2024;83:1656-1668.
    PubMed     Abstract available
    
    
    
29. VANDERVOORT PM, Deferm S
    The Course of Atrial Functional Mitral Regurgitation: The Atrium Dictates the Path.
    J Am Coll Cardiol. 2024;83:1508-1510.
    PubMed    
    
    
    
30. SOLOMON MD, Demaria A, Nishimura R, Philip F, et al
    Discordant Aortic Stenosis Parameters in Real-World Data: Do Not Ignore a Low Aortic Valve Area.
    J Am Coll Cardiol. 2024;83:e153.
    PubMed    
    
    
    
31. JABER WA, Rodriguez LL
    Treatment and Prognosis of Less Than Severe Aortic Stenosis: The Importance of Context.
    J Am Coll Cardiol. 2024;83:e151.
    PubMed    
    
    
    
32. RIAZ S, McMahon SR, Stockey K, Meyer M, et al
    Effect of Personalized Accelerated Pacing in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:1492-1493.
    PubMed    
    
    
    
33. TAYLOR MB
    Real-World Experience With the Harmony Valve: Great Results for a Common Problem.
    J Am Coll Cardiol. 2024;83:1322-1323.
    PubMed    
    
    
    
34. GOLDSTEIN BH, McElhinney DB, Gillespie MJ, Aboulhosn JA, et al
    Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry.
    J Am Coll Cardiol. 2024;83:1310-1321.
    PubMed     Abstract available
    
    
    
35. NICKENIG G, Sugiura A
    Transcatheter Myotomy for LVOT Challenges: SESAME Street 2.0.
    J Am Coll Cardiol. 2024;83:1273-1275.
    PubMed    
    
    
    
36. GREENBAUM AB, Ueyama HA, Gleason PT, Khan JM, et al
    Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction.
    J Am Coll Cardiol. 2024;83:1257-1272.
    PubMed     Abstract available
    
    
    
37. MORAS E, Gandhi K, Koshy AN, Bhatia K, et al
    Mitral Transcatheter Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:1253-1255.
    PubMed    
    
    
    March 2024
38. EGBE AC, Miranda WR, Abozied O, Jain CC, et al
    Coarctation of Aorta With Tricuspid Aortic Valve Is Not Associated With Ascending Aortic Aneurysm.
    J Am Coll Cardiol. 2024;83:1136-1146.
    PubMed     Abstract available
    
    
    
39. O'SULLIVAN CJ, O'Sullivan D
    Discordant High-Gradient Aortic Stenosis: Trust the Gradient.
    J Am Coll Cardiol. 2024;83:1120-1122.
    PubMed    
    
    
    
40. UNGER P, Powers A, Le Nezet E, Lacasse-Rioux E, et al
    Prevalence and Outcomes of Patients With Discordant High-Gradient Aortic Stenosis.
    J Am Coll Cardiol. 2024;83:1109-1119.
    PubMed     Abstract available
    
    
    
41. ASATRYAN B, Muller SA
    A Novel CMR-ECGI Lens Exposes the Electrophysiological Substrate in Subclinical HCM: A Glimmering Future Preview.
    J Am Coll Cardiol. 2024;83:1056-1058.
    PubMed    
    
    
    
42. NASER JA, Alexandrino FB, Harada T, Michelena HI, et al
    The Natural History of Atrial Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024 Mar 17:S0735-1097(24)00413.
    PubMed     Abstract available
    
    
    February 2024
43. JOY G, Lopes LR, Webber M, Ardissino AM, et al
    Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography.
    J Am Coll Cardiol. 2024 Feb 13:S0735-1097(24)00052.
    PubMed     Abstract available
    
    
    
44. KEEPANASSERIL A, Pande SN, Satheesh S, Siu SC, et al
    Reply: Risk Estimation in Valvular Heart Disease in Pregnancy.
    J Am Coll Cardiol. 2024;83:e49.
    PubMed    
    
    
    
45. THOMAS B, Ferreira VV
    Risk Estimation in Valvular Heart Disease in Pregnancy.
    J Am Coll Cardiol. 2024;83:e47.
    PubMed    
    
    
    
46. LINDMAN BR
    Innovative Methods to Tackle Longstanding Goals in Aortic Stenosis.
    J Am Coll Cardiol. 2024;83:592-594.
    PubMed    
    
    
    
47. SHELBAYA K, Arthur V, Yang Y, Dorbala P, et al
    Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis.
    J Am Coll Cardiol. 2024;83:577-591.
    PubMed     Abstract available
    
    
    January 2024
48. HIRUMA T, Kitamura M, Takamisawa I, Izumi Y, et al
    Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:546-548.
    PubMed    
    
    
    
49. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    PubMed     Abstract available
    
    
    
50. SENGUPTA A, Carreon CK, Gauvreau K, Lee JM, et al
    Growth of the Neo-Aortic Root and Prognosis of Transposition of the Great Arteries.
    J Am Coll Cardiol. 2024;83:516-527.
    PubMed     Abstract available
    
    
    
51. SECKELER MD
    The Neo-Aortic Root After Arterial Switch Operation: Defining the New Normal.
    J Am Coll Cardiol. 2024;83:528-529.
    PubMed    
    
    
    
52. EZEKOWITZ JA
    Filling in the Mitral Valve Transcatheter Edge-to-Edge Repair Data Gaps.
    J Am Coll Cardiol. 2024;83:500-502.
    PubMed    
    
    
    
53. SANNINO A, Fortuni F
    Timing Surgical Mitral Valve Repair for Primary Mitral Regurgitation: An Opportunity for Sex-Guided Precision Medicine.
    J Am Coll Cardiol. 2024;83:313-316.
    PubMed    
    
    
    
54. ABADIE BQ, Cremer PC, Vakamudi S, Gillinov AM, et al
    Sex-Specific Prognosis of Left Ventricular Size and Function Following Repair of Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:303-312.
    PubMed     Abstract available
    
    
    
55. TEN BERG JM, Overduin DC, van Ginkel DJ
    Best Oral Anticoagulant for Transcatheter Mitral Valve Replacement.
    J Am Coll Cardiol. 2024;83:347-349.
    PubMed    
    
    
    
56. EL BEZE N, Himbert D, Suc G, Brochet E, et al
    Comparison of Direct Oral Anticoagulants vs Vitamin K Antagonists After Transcatheter Mitral Valve Replacement.
    J Am Coll Cardiol. 2024;83:334-346.
    PubMed     Abstract available
    
    
    
57. SHERWOOD MW, Vora AN
    What Do We Really Know About Transcatheter Mitral Valve-in-Valve Procedures?
    J Am Coll Cardiol. 2024;83:331-333.
    PubMed    
    
    
    
58. BATCHELOR WB, Emaminia A, Sherwood MW
    Health Benefits of Transcatheter Tricuspid Valve Repair: Is it Enough to Simply Feel Better?
    J Am Coll Cardiol. 2024;83:14-16.
    PubMed    
    
    
    December 2023
59. FANG J, Liu Y, Wan S, Wei X, et al
    Reply: Potential Expanded Applications of Minimally Invasive Cardiac Myectomy.
    J Am Coll Cardiol. 2023;82:e237.
    PubMed    
    
    
    
60. PAI RG
    Potential Expanded Applications of Minimally Invasive Cardiac Myectomy.
    J Am Coll Cardiol. 2023;82:e235.
    PubMed    
    
    
    
61. EMANI SM, Del Nido PJ
    Systemic Atrioventricular Valve Regurgitation in Corrected Transposition of the Great Arteries: Where Are We?
    J Am Coll Cardiol. 2023;82:2209-2211.
    PubMed    
    
    
    November 2023
62. RANARD LS, Bonow RO, Nishimura R, Mack MJ, et al
    Imaging Methods for Evaluation of Chronic Aortic Regurgitation in Adults: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1953-1966.
    PubMed     Abstract available
    
    
    
63. COLOMBO A, Leone PP
    Adoption of TAVR in Europe vs the United States: Is it Deja-Vu?
    J Am Coll Cardiol. 2023;82:1903-1905.
    PubMed    
    
    
    October 2023
64. KASKI JP, Norrish G
    Family Screening in Gene-Elusive Hypertrophic Cardiomyopathy: Time for a Change or Should We Tread Cautiously?
    J Am Coll Cardiol. 2023;82:1762-1764.
    PubMed    
    
    
    
65. NIELSEN SK, Hansen FG, Rasmussen TB, Fischer T, et al
    Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives.
    J Am Coll Cardiol. 2023;82:1751-1761.
    PubMed     Abstract available
    
    
    
66. GENEREUX P, Sharma RP, Cubeddu RJ, Aaron L, et al
    The Mortality Burden of Untreated Aortic Stenosis.
    J Am Coll Cardiol. 2023 Oct 20:S0735-1097(23)07504.
    PubMed     Abstract available
    
    
    
67. BRAUNWALD E
    Aortic Stenosis: A 6-Decade Odyssey.
    J Am Coll Cardiol. 2023 Oct 18:S0735-1097(23)07682.
    PubMed    
    
    
    
68. FORREST JK, Deeb GM, Yakubov SJ, Gada H, et al
    4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.
    J Am Coll Cardiol. 2023 Oct 18:S0735-1097(23)07628.
    PubMed    
    
    
    
69. UEYAMA HA, Miyamoto Y, Watanabe A, Gotanda H, et al
    Cardiac Re-operation or Transcatheter Mitral Valve Replacement for Patients with Failed Mitral Prostheses.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07753.
    PubMed     Abstract available
    
    
    
70. ARNOLD SV, Goates S, Sorajja P, Adams DH, et al
    Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07743.
    PubMed     Abstract available
    
    
    
71. PROSPERI-PORTA G, Nguyen V, Willner N, Dreyfus J, et al
    Association of Age and Sex With Use of Transcatheter Aortic Valve Replacement in France.
    J Am Coll Cardiol. 2023 Oct 11:S0735-1097(23)06649.
    PubMed     Abstract available
    
    
    
72. SUNDER-PLASSMANN G, Graf S, Gatterer C
    Staging of Fabry Cardiomyopathy by Echocardiography: Back to the Roots?
    J Am Coll Cardiol. 2023;82:1535-1537.
    PubMed    
    
    
    
73. MALAHFJI M, Nguyen DT, Graviss EA, Shah DJ, et al
    Reply: Cardiac Remodeling in Aortic Regurgitation.
    J Am Coll Cardiol. 2023;82:e125.
    PubMed    
    
    
    
74. PAI RG
    Left Ventricular Remodeling in Aortic Regurgitation.
    J Am Coll Cardiol. 2023;82:e123.
    PubMed    
    
    
    
75. LIU B, Jiang X, Gu T
    Bicuspid Aortic Valve: An Anomaly to Be Reckoned With.
    J Am Coll Cardiol. 2023;82:e121.
    PubMed    
    
    
    
76. SHARMA G, Mehta A, Scott NS
    Risk Estimation in Valvular Heart Disease in Pregnancy: An Idea Whose Time Has Come.
    J Am Coll Cardiol. 2023;82:1407-1410.
    PubMed    
    
    
    
77. PANDE SN, Yavana Suriya J, Ganapathy S, Pillai AA, et al
    Validation of Risk Stratification for Cardiac Events in Pregnant Women With Valvular Heart Disease.
    J Am Coll Cardiol. 2023;82:1395-1406.
    PubMed     Abstract available
    
    
    
78. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    PubMed     Abstract available
    
    
    September 2023
79. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    J Am Coll Cardiol. 2023 Sep 28:S0735-1097(23)06403.
    PubMed     Abstract available
    
    
    
80. GOEL K, Lindenfeld J, Makkar R, Naik H, et al
    Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    J Am Coll Cardiol. 2023;82:1281-1297.
    PubMed     Abstract available
    
    
    
81. MCELHINNEY DB, Asija R, Zhang Y, Jaggi A, et al
    20-Year Experience With Repair of Pulmonary Atresia or Stenosis and Major Aortopulmonary Collateral Arteries.
    J Am Coll Cardiol. 2023;82:1206-1222.
    PubMed     Abstract available
    
    
    
82. DAVID TE, Park J, Tatangelo M, Steve Fan CP, et al
    Cardiovascular Events After Aortic Root Repair in Patients With Marfan Syndrome.
    J Am Coll Cardiol. 2023;82:1068-1076.
    PubMed     Abstract available
    
    
    August 2023
83. COISNE A, Lancellotti P, Habib G, Garbi M, et al
    ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison.
    J Am Coll Cardiol. 2023;82:721-734.
    PubMed     Abstract available
    
    
    
84. ELKARYONI A
    Extravalvular Myocardial Damage and Aortic Valve Replacement.
    J Am Coll Cardiol. 2023;82:e67.
    PubMed    
    
    
    
85. SCHAFF HV, Cui H
    Septal Myectomy: An Evolving Therapy for Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;82:587-589.
    PubMed    
    
    
    
86. FANG J, Liu Y, Zhu Y, Li R, et al
    First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    J Am Coll Cardiol. 2023;82:575-586.
    PubMed     Abstract available
    
    
    
87. BADHWAR V, Mehaffey JH, Habib RH
    REPLY: Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation.
    J Am Coll Cardiol. 2023;82:e47-e48.
    PubMed    
    
    
    
88. OLSTHOORN JR, Verberkmoes N, Nia PS, Heuts S, et al
    Surgical Risk Scores in Mitral Valve Surgery and the Danger of Channeling Bias.
    J Am Coll Cardiol. 2023;82:e45.
    PubMed    
    
    
    
89. ALKHOULI M
    Surgical Mitral Valve Repair: Excellent Outcomes, But for the Selected Few?
    J Am Coll Cardiol. 2023;82:e43.
    PubMed    
    
    
    
90. VALENTE AM, Harrild DM, Beroukhim RS
    Ebstein Anomaly: More Than Just a Tricuspid Valve Issue.
    J Am Coll Cardiol. 2023;82:514-516.
    PubMed    
    
    
    
91. GRAPSA J, Pinney SP
    Right Heart Dysfunction in HFpEF: More Complex and More Common Than We Thought.
    J Am Coll Cardiol. 2023;82:500-502.
    PubMed    
    
    
    
92. RODRIGUEZ-PALOMARES JF, Dux-Santoy L, Guala A, Galian-Gay L, et al
    Mechanisms of Aortic Dilation in Patients With Bicuspid Aortic Valve: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:448-464.
    PubMed     Abstract available
    
    
    July 2023
93. MARON MS, Mitten M, Borchers J, Rowin EJ, et al
    Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.
    J Am Coll Cardiol. 2023 Jul 27:S0735-1097(23)06030.
    PubMed    
    
    
    
94. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
    Reply: Diagnosing Prosthesis-Patient Mismatch Without Real Echocardiographic Assessments: Are We Studying This Incorrectly?
    J Am Coll Cardiol. 2023;82:e29.
    PubMed    
    
    
    
95. YANG B, Chen EP, Ailawadi G, Reardon MJ, et al
    Diagnosing Prosthesis-Patient Mismatch Without Real Echocardiographic Assessments: Are We Studying This Incorrectly?
    J Am Coll Cardiol. 2023;82:e27.
    PubMed    
    
    
    
96. RODES-CABAU J, Januzzi JL Jr, Mack MJ
    Tricuspid Transcatheter Repair: Edging Toward Prime Time?
    J Am Coll Cardiol. 2023;82:292-294.
    PubMed    
    
    
    
97. LURZ P, Besler C, Schmitz T, Bekeredjian R, et al
    Short-Term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice.
    J Am Coll Cardiol. 2023;82:281-291.
    PubMed     Abstract available
    
    
    
98. BURCZAK DR, Julakanti RR, Kara Balla A, Scott CG, et al
    Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:278-279.
    PubMed    
    
    
    
99. MADHAVAN MV, Kodali SK, Thourani VH, Makkar R, et al
    Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
    J Am Coll Cardiol. 2023;82:109-123.
    PubMed     Abstract available
    
    
    
100. ANKER MS, von Haehling S, Landmesser U
     Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.
     J Am Coll Cardiol. 2023;82:139-141.
     PubMed    
     
     
     
101. VERMA S, Bhatt DL, Tang GHL
     Mid-Term Outcomes of TAVR in Intermediate-Risk Patients: Potential Targets for Improvement.
     J Am Coll Cardiol. 2023;82:124-127.
     PubMed    
     
     
     
102. GRINSTEIN J, Belkin MN, Kalantari S, Bourque K, et al
     Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;82:70-81.
     PubMed     Abstract available
     
     
     May 2023
103. SCOTTI A, Coisne A, Granada JF, Driggin E, et al
     Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2023 May 27:S0735-1097(23)05584.
     PubMed     Abstract available
     
     
     
104. KOVACS AH, Lebovic G, Raptis S, Blais S, et al
     Patient-Reported Outcomes After Tetralogy of Fallot Repair.
     J Am Coll Cardiol. 2023;81:1937-1950.
     PubMed     Abstract available
     
     
     
105. SANNINO A, Meucci MC
     Advances in Risk Stratification of Chronic Aortic Regurgitation: Time for a Change in Guidelines?
     J Am Coll Cardiol. 2023;81:1899-1901.
     PubMed    
     
     
     
106. BATCHELOR WB, Emaminia A, Epps K
     CLASP TR EFS 1-Year Results: Coming of Age of Tricuspid Valve Edge-to-Edge Repair?
     J Am Coll Cardiol. 2023;81:1777-1779.
     PubMed    
     
     
     
107. KODALI SK, Hahn RT, Davidson CJ, Narang A, et al
     1-Year Outcomes of Transcatheter Tricuspid Valve Repair.
     J Am Coll Cardiol. 2023;81:1766-1776.
     PubMed     Abstract available
     
     
     
108. STOLZ L, Weckbach LT, Hahn RT, Chatfield AG, et al
     2-Year Outcomes Following Transcatheter Tricuspid Valve Replacement Using the EVOQUE System.
     J Am Coll Cardiol. 2023 May 9:S0735-1097(23)05421.
     PubMed    
     
     
     
109. PIBAROT P
     Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients: So Far (3 Years), So Good.
     J Am Coll Cardiol. 2023;81:1675-1679.
     PubMed    
     
     
     April 2023
110. PATLOLLA SH, Schaff HV
     Reply: Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
     J Am Coll Cardiol. 2023;81:e141.
     PubMed    
     
     
     
111. BONAPACE S, Marinelli A, Costa A, Trachanas K, et al
     Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker: A Vicious Circle.
     J Am Coll Cardiol. 2023;81:e139.
     PubMed    
     
     
     
112. ASNANI A
     New Insights Into Cardiac Wasting in Patients With Cancer.
     J Am Coll Cardiol. 2023;81:1587-1589.
     PubMed    
     
     
     
113. SIMARD T, Vemulapalli S, Hibbert B, Alkhouli M, et al
     Reply: Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:e131.
     PubMed    
     
     
     
114. ELKARYONI A, Stone GW
     Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:e129.
     PubMed    
     
     
     
115. SANNINO A, Fortuni F
     Timing for Intervention in Aortic Regurgitation: When One Does Not Fit All.
     J Am Coll Cardiol. 2023;81:1488-1490.
     PubMed    
     
     
     
116. AKINTOYE E, Saijo Y, Braghieri L, Badwan O, et al
     Impact of Age and Sex on Left Ventricular Remodeling in Patients With Aortic Regurgitation.
     J Am Coll Cardiol. 2023;81:1474-1487.
     PubMed     Abstract available
     
     
     
117. GEDDES GC, Parent JJ, Lander J, Jeewa A, et al
     MEK Inhibition Improves Cardiomyopathy in Costello Syndrome.
     J Am Coll Cardiol. 2023;81:1439-1441.
     PubMed    
     
     
     
118. MALLAT Z
     Fishing CHIPs to Predict Postoperative Atrial Fibrillation.
     J Am Coll Cardiol. 2023;81:1279-1282.
     PubMed    
     
     
     
119. SORAJJA P, Cavalcante JL, Rodes-Cabau J
     Upstream Relief of Heart Failure Via Aortic Valve Replacement.
     J Am Coll Cardiol. 2023;81:1245-1247.
     PubMed    
     
     
     
120. KHAN KR, Khan OA, Chen C, Liu Y, et al
     Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction.
     J Am Coll Cardiol. 2023;81:1235-1244.
     PubMed     Abstract available
     
     
     March 2023
121. LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al
     Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:1035-1045.
     PubMed     Abstract available
     
     
     
122. CORDOVES EM, Vunjak-Novakovic G, Kalfa DM
     Designing Biocompatible Tissue Engineered Heart Valves In Situ: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2023;81:994-1003.
     PubMed     Abstract available
     
     
     
123. MACK MJ, Adams DH
     Avoidance of Patient Prosthesis Mismatch After Aortic Valve Replacement: Have We Been Too Aggressive?
     J Am Coll Cardiol. 2023;81:976-978.
     PubMed    
     
     
     
124. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
     Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
     J Am Coll Cardiol. 2023;81:964-975.
     PubMed     Abstract available
     
     
     
125. MALAHFJI M, Crudo V, Kaolawanich Y, Nguyen DT, et al
     Association of Cardiac Remodeling with Aortic Regurgitation Outcomes: The AR Consortium of the SCMR Registry.
     J Am Coll Cardiol. 2023 Mar 3:S0735-1097(23)04582.
     PubMed     Abstract available
     
     
     February 2023
126. ASCHER SB, de Lemos JA, Lee M, Berry JD, et al
     Reply: Malignant Hypertensive Cardiomyopathy: Definition Matters.
     J Am Coll Cardiol. 2023;81:e59.
     PubMed    
     
     
     
127. FUSTER V
     Editor-in-Chief's Top Picks From 2022.
     J Am Coll Cardiol. 2023;81:780-841.
     PubMed     Abstract available
     
     
     
128. COYLEWRIGHT M, Januzzi JL, Szerlip M
     Options to Improve Quality of Life for Aortic Stenosis: "No Decision About Me, Without Me".
     J Am Coll Cardiol. 2023;81:753-755.
     PubMed    
     
     
     
129. GENEREUX P, Cohen DJ, Pibarot P, Redfors B, et al
     Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.
     J Am Coll Cardiol. 2023;81:743-752.
     PubMed     Abstract available
     
     
     
130. FORREST JK, Deeb GM, Yakubov SJ, Gada H, et al
     Three-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.
     J Am Coll Cardiol. 2023 Feb 24:S0735-1097(23)00411.
     PubMed     Abstract available
     
     
     
131. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
     Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
     J Am Coll Cardiol. 2023;81:708-710.
     PubMed    
     
     
     
132. AVVEDIMENTO M, Nuche J, Farjat-Pasos JI, Rodes-Cabau J, et al
     Bleeding Events After Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:684-702.
     PubMed     Abstract available
     
     
     
133. GERGES C, Pistritto AM, Gerges M, Friewald R, et al
     Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
     J Am Coll Cardiol. 2023;81:653-664.
     PubMed     Abstract available
     
     
     
134. ANYANWU AC, Adams DH
     Benchmarking Mitral Valve Repair: Defining Standards for Surgical and Percutaneous Treatment of Severe Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:649-652.
     PubMed    
     
     
     
135. LOWENSTERN AM, Vekstein AM, Grau-Sepulveda M, Badhwar V, et al
     Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair.
     J Am Coll Cardiol. 2023;81:521-532.
     PubMed     Abstract available
     
     
     
136. JOSEPH MS, Bach DS
     Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation With Complex Mitral Valve Anatomy.
     J Am Coll Cardiol. 2023;81:443-445.
     PubMed    
     
     
     
137. HAUSLEITER J, Lim DS, Gillam LD, Zahr F, et al
     Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation.
     J Am Coll Cardiol. 2023;81:431-442.
     PubMed     Abstract available
     
     
     January 2023
138. DEL VAL D, Panagides V, Mestres CA, Miro JM, et al
     Infective Endocarditis After Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;81:394-412.
     PubMed     Abstract available
     
     
     
139. HAN Y, Chen T, Addetia K
     Tricuspid Valve Prolapse: A Forgotten Mechanism of Primary Tricuspid Regurgitation?
     J Am Coll Cardiol. 2023 Jan 27:S0735-1097(22)07643.
     PubMed    
     
     
     
140. GUTA AC, El-Tallawi KC, Nguyen DT, Qamar F, et al
     Prevalence and Clinical Implications of Tricuspid Valve Prolapse Based on Magnetic Resonance Diagnostic Criteria.
     J Am Coll Cardiol. 2023 Jan 27:S0735-1097(22)07642.
     PubMed     Abstract available
     
     
     
141. HECHT S, Bax JJ, Pibarot P
     Reply: Outcomes in Bicuspid Aortic Valve Disease.
     J Am Coll Cardiol. 2023;81:e25.
     PubMed    
     
     
     
142. PAI RG
     Outcomes in Bicuspid Aortic Valve Disease.
     J Am Coll Cardiol. 2023;81:e23.
     PubMed    
     
     
     
143. MARON MS
     Increased Long-Term Survival After Myectomy: Is the Pendulum Swinging Again in This 30-Year Debate?
     J Am Coll Cardiol. 2023;81:116-118.
     PubMed    
     
     
     
144. MENTIAS A, Smedira NG, Krishnaswamy A, Reed GW, et al
     Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:105-115.
     PubMed     Abstract available
     
     
     
145. BADHWAR V, Chikwe J, Gillinov AM, Vemulapalli S, et al
     Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation.
     J Am Coll Cardiol. 2023 Jan 10:S0735-1097(22)07418.
     PubMed     Abstract available
     
     
     
146. NAIR A, Xie L, Silva Enciso JE
     Myosin Inhibitors: The Next Generation.
     J Am Coll Cardiol. 2023;81:46-48.
     PubMed    
     
     
     
147. MARON MS, Masri A, Choudhury L, Olivotto I, et al
     Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2023;81:34-45.
     PubMed     Abstract available
     
     
     December 2022
148. DELLING FN, Noseworthy PA, Adams DH, Basso C, et al
     Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel.
     J Am Coll Cardiol. 2022;80:2331-2347.
     PubMed     Abstract available
     
     
     
149. FARHAN S, Silbiger JJ, Halperin JL, Zhang L, et al
     Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:2314-2330.
     PubMed     Abstract available
     
     
     
150. RUF TF, Gossler TAM, von Bardeleben RS
     Understanding Atrial Fibrillation and Atrial Secondary Tricuspid Regurgitation: The Chicken or the Egg?
     J Am Coll Cardiol. 2022;80:2299-2300.
     PubMed    
     
     
     
151. PATLOLLA SH, Schaff HV, Nishimura RA, Stulak JM, et al
     Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2022;80:2289-2298.
     PubMed     Abstract available
     
     
     
152. MARSIT O, Levine RA, Beaudoin J
     Reply: Another Road to Rome: Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2022;80:e215.
     PubMed    
     
     
     
153. JIANG X, Liu J, Gu T
     Another Road to Rome: Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2022;80:e213-e214.
     PubMed    
     
     
     
154. WIDMER RJ, Szerlip M
     Percutaneous Mitral Valve Replacement: The Drum Beats on and Louder.
     J Am Coll Cardiol. 2022;80:2184-2186.
     PubMed    
     
     
     
155. ELEID MF, Wang DD, Pursnani A, Kodali SK, et al
     2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses.
     J Am Coll Cardiol. 2022;80:2171-2183.
     PubMed     Abstract available
     
     
     November 2022
156. LURZ P, Besler C
     Transcatheter Treatment of Mitral Regurgitation in Cardiogenic Shock: Promises and Pitfalls.
     J Am Coll Cardiol. 2022;80:2085-2088.
     PubMed    
     
     
     
157. CARABELLO BA
     Secondary Mitral Regurgitation: It Is Still the Ventricle.
     J Am Coll Cardiol. 2022;80:1869-1870.
     PubMed    
     
     
     
158. GIUSTINO G, Camaj A, Kapadia SR, Kar S, et al
     Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
     J Am Coll Cardiol. 2022;80:1857-1868.
     PubMed     Abstract available
     
     
     October 2022
159. GENEREUX P
     Pulmonary Hypertension and Aortic Stenosis: A Piece of the Puzzle.
     J Am Coll Cardiol. 2022;80:1614-1616.
     PubMed    
     
     
     
160. MIYAMOTO J, Ohno Y, Kamioka N, Ikari Y, et al
     Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2022;80:1601-1613.
     PubMed     Abstract available
     
     
     
161. COLLET JP, Rahoual G, Hulot JS
     Clonal Hematopoiesis in Cardiogenic Shock: Beyond Conventional Prognostication?
     J Am Coll Cardiol. 2022;80:1557-1559.
     PubMed    
     
     
     
162. BASU J, Finocchiaro G, Jayakumar S, Schonfeld J, et al
     Impact of Exercise on Outcomes and Phenotypic Expression in Athletes With Nonobstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;80:1498-1500.
     PubMed    
     
     
     
163. LANFEAR DE, Reza N
     Myosin-Related Dilated Cardiomyopathy: Another Elephant Emerges From Darkness.
     J Am Coll Cardiol. 2022;80:1462-1464.
     PubMed    
     
     
     September 2022
164. HECHT S, Butcher SC, Pio SM, Kong WKF, et al
     Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease.
     J Am Coll Cardiol. 2022;80:1071-1084.
     PubMed     Abstract available
     
     
     
165. SENGUPTA A, Beroukhim R, Baird CW, Del Nido PJ, et al
     Outcomes of Repair of Congenital Aortic Valve Lesions Using Autologous Pericardium vs Porcine Intestinal Submucosa.
     J Am Coll Cardiol. 2022;80:1060-1068.
     PubMed     Abstract available
     
     
     
166. CUI H, Schaff HV
     Reply: Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment.
     J Am Coll Cardiol. 2022;80:e89.
     PubMed    
     
     
     
167. MOUKARBEL GV, Cooper CJ
     Long-Term Mortality in Obstructive Hypertrophic Cardiomyopathy: Looking Beyond the Assigned Treatment.
     J Am Coll Cardiol. 2022;80:e87.
     PubMed    
     
     
     
168. KOVACIC JC, Fuster V
     Exercise, Cardiovascular Disease, and the Athlete's Heart.
     J Am Coll Cardiol. 2022;80:1088-1090.
     PubMed    
     
     
     
169. DONAL E, Magne J, Cosyns B
     Left Ventricular Ejection Fraction Thresholds Reappraisal: Also for Bicuspid Valve Disease?
     J Am Coll Cardiol. 2022;80:1085-1087.
     PubMed    
     
     
     
170. MA M
     Are There Still Reasons to Use Porcine Small Intestinal Submucosa?
     J Am Coll Cardiol. 2022;80:1069-1070.
     PubMed    
     
     
     
171. SIMARD T, Vemulapalli S, Jung RG, Vekstein A, et al
     Transcatheter Edge-to-Edge Repair in Patients with Severe Mitral Regurgitation and Cardiogenic Shock: TVT Registry Analysis.
     J Am Coll Cardiol. 2022 Sep 13. pii: S0735-1097(22)06767.
     PubMed     Abstract available
     
     
     
172. SHARMA T, Krishnan AM, Lahoud R, Polomsky M, et al
     National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis.
     J Am Coll Cardiol. 2022 Sep 8. pii: S0735-1097(22)06756.
     PubMed    
     
     
     August 2022
173. PARIKH PB
     Predicting Futility in Aortic Stenosis: What's the Holdup?
     J Am Coll Cardiol. 2022;80:801-803.
     PubMed    
     
     
     
174. SEMSARIAN C, Gray B, Haugaa KH, Lampert R, et al
     Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases: JACC Focus Seminar 3/4.
     J Am Coll Cardiol. 2022 Aug 19. pii: S0735-1097(22)05663.
     PubMed     Abstract available
     
     
     
175. CHURCHILL TW, Yucel E, Deferm S, Levine RA, et al
     Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;80:739-751.
     PubMed     Abstract available
     
     
     
176. HAYASHIDA K
     Transcatheter Valve Treatment for a Failed Small Surgical Aortic Valve: Addressing the Achilles' Heel.
     J Am Coll Cardiol. 2022;80:694-696.
     PubMed    
     
     
     
177. OH JK, Ito S
     Severity of Aortic Stenosis: A Moving Target.
     J Am Coll Cardiol. 2022;80:677-680.
     PubMed    
     
     
     
178. STASSEN J, Ewe SH, Singh GK, Butcher SC, et al
     Prevalence and Prognostic Implications of Discordant Grading and Flow-Gradient Patterns in Moderate Aortic Stenosis.
     J Am Coll Cardiol. 2022;80:666-676.
     PubMed     Abstract available
     
     
     
179. CHEHAB O, Roberts-Thomson R, Bivona A, Gill H, et al
     Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:722-738.
     PubMed     Abstract available
     
     
     
180. RODES-CABAU J, Abbas AE, Serra V, Vilalta V, et al
     Balloon- vs Self-Expanding Valve Systems for Failed Small Surgical Aortic Valve Bioprostheses.
     J Am Coll Cardiol. 2022;80:681-693.
     PubMed     Abstract available
     
     
     
181. PANDEY A, Adedinsewo D
     The Future of AI-Enhanced ECG Interpretation for Valvular Heart Disease Screening.
     J Am Coll Cardiol. 2022;80:627-630.
     PubMed    
     
     
     
182. ELIAS P, Poterucha TJ, Rajaram V, Moller LM, et al
     Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.
     J Am Coll Cardiol. 2022;80:613-626.
     PubMed     Abstract available
     
     
     
183. PIBAROT P, Herrmann HC, Wu C, Hahn RT, et al
     Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:545-561.
     PubMed     Abstract available
     
     
     
184. HERRMANN HC, Pibarot P, Wu C, Hahn RT, et al
     Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;80:527-544.
     PubMed     Abstract available
     
     
     
185. BEERI R
     Ischemic Mitral Regurgitation and Leaflet Remodeling: Another Arrow Hits the Target.
     J Am Coll Cardiol. 2022;80:511-512.
     PubMed    
     
     
     
186. MARSIT O, Clavel MA, Paquin A, Deschenes V, et al
     Effects of Cyproheptadine on Mitral Valve Remodeling and Regurgitation After Myocardial Infarction.
     J Am Coll Cardiol. 2022;80:500-510.
     PubMed     Abstract available
     
     
     
187. NEKOUI M, Pirruccello JP, Di Achille P, Choi SH, et al
     Spatially Distinct Genetic Determinants of Aortic Dimensions Influence Risks of Aneurysm and Stenosis.
     J Am Coll Cardiol. 2022;80:486-497.
     PubMed     Abstract available
     
     
     July 2022
188. HARIRI EH, Kassis N, Badwan OZ, Al Hammoud MM, et al
     Impact of Oral Anticoagulation on Progression and Long-Term Outcomes of Mild or Moderate Aortic Stenosis.
     J Am Coll Cardiol. 2022;80:181-183.
     PubMed    
     
     
     
189. DESAI MY, Owens A, Geske JB, Wolski K, et al
     Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.
     J Am Coll Cardiol. 2022;80:95-108.
     PubMed     Abstract available
     
     
     
190. OMMEN SR
     Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: Where Are We on the Hype Cycle?
     J Am Coll Cardiol. 2022;80:109-110.
     PubMed    
     
     
     June 2022
191. DALEN M, Persson M, Glaser N, Sartipy U, et al
     Socioeconomic Status and Risk of Bleeding After Mechanical Aortic Valve Replacement.
     J Am Coll Cardiol. 2022;79:2502-2513.
     PubMed     Abstract available
     
     
     
192. RAPOSEIRAS-ROUBIN S, Abu Assi E, Estevez Loureiro R, Iniguez Romo A, et al
     Reply: Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair.
     J Am Coll Cardiol. 2022;79:e479.
     PubMed    
     
     
     
193. SPIEKER M, Zweck E, Pfister R, Ulrich Becher M, et al
     Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair.
     J Am Coll Cardiol. 2022;79:e477-e478.
     PubMed    
     
     
     May 2022
194. HOLMES KW, Markwardt S, Eagle KA, Devereux RB, et al
     Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.
     J Am Coll Cardiol. 2022;79:2069-2081.
     PubMed     Abstract available
     
     
     
195. ROSSANO JW, Lin KY
     Hypertrophic Cardiomyopathy: A Problem at Any Age.
     J Am Coll Cardiol. 2022;79:1998-2000.
     PubMed    
     
     
     
196. NORRISH G, Cleary A, Field E, Cervi E, et al
     Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1986-1997.
     PubMed     Abstract available
     
     
     
197. GENEREUX P, Pibarot P, Redfors B, Bax JJ, et al
     Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.
     J Am Coll Cardiol. 2022 May 14. pii: S0735-1097(22)04979.
     PubMed     Abstract available
     
     
     
198. DORFMAN AL, Del Nido PJ
     The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
     J Am Coll Cardiol. 2022;79:1846-1848.
     PubMed    
     
     
     
199. SHERRID MV, Massera D, Swistel DG
     Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
     J Am Coll Cardiol. 2022;79:1656-1659.
     PubMed    
     
     
     
200. CUI H, Schaff HV, Wang S, Lahr BD, et al
     Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1647-1655.
     PubMed     Abstract available
     
     
     April 2022
201. BORLAUG BA, Omote K
     Beta-Blockers and Exercise Hemodynamics in Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1576-1578.
     PubMed    
     
     
     
202. DYBRO AM, Rasmussen TB, Nielsen RR, Ladefoged BT, et al
     Effects of Metoprolol on Exercise Hemodynamics in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1565-1575.
     PubMed     Abstract available
     
     
     
203. LAMPERT J, Pulaski M, Miller MA, Whang W, et al
     Right Precordial U-Waves in Severe Aortic Stenosis: "Real World" Prevalence and Diminution by TAVR.
     J Am Coll Cardiol. 2022 Apr 20. pii: S0735-1097(22)04813.
     PubMed    
     
     
     
204. HAHN RT, Clavel MA, Mascherbauer J, Mick SL, et al
     Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7.
     J Am Coll Cardiol. 2022;79:1506-1518.
     PubMed     Abstract available
     
     
     
205. AKODAD M, Blanke P, Chuang MA, Duchscherer J, et al
     Late Balloon Valvuloplasty for Transcatheter Heart Valve Dysfunction.
     J Am Coll Cardiol. 2022;79:1340-1351.
     PubMed     Abstract available
     
     
     
206. SZERLIP M, Mack MJ
     The Management of Transcatheter Heart Valve Dysfunction: Another Tool in the Box.
     J Am Coll Cardiol. 2022;79:1352-1355.
     PubMed    
     
     
     
207. ITCHHAPORIA D
     TAVR 20 Years Later: A Story of Disruptive Transformation.
     J Am Coll Cardiol. 2022;79:1314-1316.
     PubMed    
     
     
     March 2022
208. AMBARDEKAR AV, Stratton MS, Weiser-Evans MCM, Moulton KS, et al
     Reply: Aortic Valve Remodeling in CF-LVAD: Beyond the Arterial Wall.
     J Am Coll Cardiol. 2022;79:e223.
     PubMed    
     
     
     
209. GAZZOLI F, Urtis M, Pagani F, Pelenghi S, et al
     Aortic Valve Remodeling in CF-LVAD: Beyond the Arterial Wall.
     J Am Coll Cardiol. 2022;79:e221-e222.
     PubMed    
     
     
     
210. MAZINE A, David TE, Stoklosa K, Chung J, et al
     Improved Outcomes Following the Ross Procedure Compared With Bioprosthetic Aortic Valve Replacement.
     J Am Coll Cardiol. 2022;79:993-1005.
     PubMed     Abstract available
     
     
     
211. MARWICK TH, Brugger N
     Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
     J Am Coll Cardiol. 2022;79:962-964.
     PubMed    
     
     
     
212. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
     Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
     J Am Coll Cardiol. 2022;79:951-961.
     PubMed     Abstract available
     
     
     
213. OZKAN M, Gunduz S, Guner A, Kalcik M, et al
     Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study.
     J Am Coll Cardiol. 2022;79:977-989.
     PubMed     Abstract available
     
     
     
214. TISON GH, Siontis KC, Abreau S, Attia Z, et al
     Assessment of Disease Status and Treatment Response With Artificial Intelligence-Enhanced Electrocardiography in Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:1032-1034.
     PubMed    
     
     
     
215. EL-HAMAMSY I, O'Gara PT, Adams DH
     The Ross Procedure: Clinical Relevance, Guidelines Recognition, and Centers of Excellence.
     J Am Coll Cardiol. 2022;79:1006-1009.
     PubMed    
     
     
     
216. FORREST JK, Deeb GM, Yakubov SJ, Rovin JD, et al
     2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.
     J Am Coll Cardiol. 2022;79:882-896.
     PubMed     Abstract available
     
     
     
217. LINDMAN BR, Lowenstern A
     The Alarm Blares for Undertreatment of Aortic Stenosis: How Will We Respond?
     J Am Coll Cardiol. 2022;79:878-881.
     PubMed    
     
     
     
218. LI SX, Patel NK, Flannery LD, Selberg A, et al
     Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis.
     J Am Coll Cardiol. 2022;79:864-877.
     PubMed     Abstract available
     
     
     
219. THOURANI VH, Yadav PK, Prendergast B
     TAVR Sustains Its Promise in Low-Risk Patients, But the Journey Is Far From Over.
     J Am Coll Cardiol. 2022;79:897-899.
     PubMed    
     
     
     
220. EL-HAMAMSY I, Toyoda N, Itagaki S, Stelzer P, et al
     Propensity-Matched Comparison of the Ross Procedure and Prosthetic Aortic Valve Replacement in Adults.
     J Am Coll Cardiol. 2022;79:805-815.
     PubMed     Abstract available
     
     
     
221. CHIKWE J
     Evidence Gaps and Endocarditis After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2022;79:786-788.
     PubMed    
     
     
     
222. MANGNER N, Val DD, Abdel-Wahab M, Crusius L, et al
     Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation.
     J Am Coll Cardiol. 2022;79:772-785.
     PubMed     Abstract available
     
     
     
223. VALLE JA, Fullerton D, Cleveland J, Messenger JC, et al
     Reply: Rational Dispersion of TAVR: The Role of Training Centers.
     J Am Coll Cardiol. 2022;79:e187.
     PubMed    
     
     
     
224. PANT S
     Rational Dispersion of TAVR: The Role of Training Centers.
     J Am Coll Cardiol. 2022;79:e185.
     PubMed    
     
     
     February 2022
225. RAPOSEIRAS-ROUBIN S, Adamo M, Freixa X, Arzamendi D, et al
     A Score to Assess Mortality After Percutaneous Mitral Valve Repair.
     J Am Coll Cardiol. 2022;79:562-573.
     PubMed     Abstract available
     
     
     
226. KALTOFT M, Langsted A, Afzal S, Kamstrup PR, et al
     Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
     J Am Coll Cardiol. 2022;79:545-558.
     PubMed     Abstract available
     
     
     
227. ALKHOULI M, Palacios IF, Jneid H
     Risk Stratification of Patients Undergoing Mitral TEER.
     J Am Coll Cardiol. 2022;79:574-576.
     PubMed    
     
     
     
228. RUDSKI LG, Afilalo J
     Right Ventricle-Pulmonary Artery Coupling in Percutaneous Tricuspid Valve Repair: Is Simple Sufficient?
     J Am Coll Cardiol. 2022;79:462-464.
     PubMed    
     
     
     
229. BRENER MI, Lurz P, Hausleiter J, Rodes-Cabau J, et al
     Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair.
     J Am Coll Cardiol. 2022;79:448-461.
     PubMed     Abstract available
     
     
     
230. MARON BJ, Desai MY, Nishimura RA, Spirito P, et al
     Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:390-414.
     PubMed     Abstract available
     
     
     
231. MARON BJ, Desai MY, Nishimura RA, Spirito P, et al
     Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:372-389.
     PubMed     Abstract available
     
     
     January 2022
232. MACK MJ, Leon MB, Wu C, Zuckerman B, et al
     The Heart Valve Collaboratory: A Disruptive Model in the Management of Valvular Heart Disease.
     J Am Coll Cardiol. 2022;79:192-196.
     PubMed    
     
     
     
233. MENTIAS A, Keshvani N, Desai MY, Kumbhani DJ, et al
     Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric.
     J Am Coll Cardiol. 2022;79:132-144.
     PubMed     Abstract available
     
     
     
234. SHERWOOD MW, Vora AN
     For TAVR, Home Is Where the Heart Is.
     J Am Coll Cardiol. 2022;79:145-147.
     PubMed    
     
     
     December 2021
235. URETSKY S, Morales DCV, Aldaia L, Mediratta A, et al
     Characterization of Primary Mitral Regurgitation With Flail Leaflet and/or Wall-Impinging Flow.
     J Am Coll Cardiol. 2021;78:2537-2546.
     PubMed     Abstract available
     
     
     
236. SHAH DJ, El-Tallawi KC
     Not All Flails Are Created Equal.
     J Am Coll Cardiol. 2021;78:2547-2549.
     PubMed    
     
     
     
237. MASRI A
     A New Dawn in HCM: Rise of the RCTs.
     J Am Coll Cardiol. 2021;78:2533-2536.
     PubMed    
     
     
     
238. HEGDE SM, Lester SJ, Solomon SD, Michels M, et al
     Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:2518-2532.
     PubMed     Abstract available
     
     
     
239. DYBRO AM, Rasmussen TB, Nielsen RR, Andersen MJ, et al
     Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:2505-2517.
     PubMed     Abstract available
     
     
     
240. NTUSI NAB, Sliwa K
     Associations of Race and Ethnicity With Presentation and Outcomes of Hypertrophic Cardiomyopathy: JACC Focus Seminar 6/9.
     J Am Coll Cardiol. 2021;78:2573-2579.
     PubMed     Abstract available
     
     
     
241. GRAYBURN PA, Packer M
     The Complex Phenotypic Expressions of Functional Mitral Regurgitation.
     J Am Coll Cardiol. 2021;78:2422-2424.
     PubMed    
     
     
     
242. LAMPREA-MONTEALEGRE JA, Oyetunji S, Bagur R, Otto CM, et al
     Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9.
     J Am Coll Cardiol. 2021;78:2493-2504.
     PubMed     Abstract available
     
     
     
243. KOELL B, Orban M, Weimann J, Kassar M, et al
     Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.
     J Am Coll Cardiol. 2021;78:2408-2421.
     PubMed     Abstract available
     
     
     
244. LINDMAN BR, Sukul D, Dweck MR, Madhavan MV, et al
     Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:2354-2376.
     PubMed     Abstract available
     
     
     
245. CHIKWE J, O'Gara P, Gelijns A
     Reply: Reconsider the MitraClip for High-Risk Patients.
     J Am Coll Cardiol. 2021;78:e295.
     PubMed    
     
     
     
246. JIANG X, Liu J, Gu T
     Reconsider the MitraClip for High-Risk Patients.
     J Am Coll Cardiol. 2021;78:e293.
     PubMed    
     
     
     November 2021
247. VEMULAPALLI S, Thourani VH
     Aortic Valve Replacement and Patient-Centered Implementation: To Boldly Go Where No Device Has Gone Before.
     J Am Coll Cardiol. 2021;78:2173-2176.
     PubMed    
     
     
     
248. MORI M, Gupta A, Wang Y, Vahl T, et al
     Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States.
     J Am Coll Cardiol. 2021;78:2161-2172.
     PubMed     Abstract available
     
     
     
249. MARTINSSON A, Nielsen SJ, Milojevic M, Redfors B, et al
     Life Expectancy After Surgical Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;78:2147-2157.
     PubMed     Abstract available
     
     
     
250. O'GARA PT, Sun YP, Patel SM
     Referral for Intervention in Severe Symptomatic Aortic Stenosis: Some Progress But Further Room for Improvement.
     J Am Coll Cardiol. 2021;78:2144-2146.
     PubMed    
     
     
     
251. EUGENE M, Duchnowski P, Prendergast B, Wendler O, et al
     Contemporary Management of Severe Symptomatic Aortic Stenosis.
     J Am Coll Cardiol. 2021;78:2131-2143.
     PubMed     Abstract available
     
     
     
252. GLASER N
     Can TAVR Match the Excellent Survival After SAVR in Younger, Low-Risk Patients?
     J Am Coll Cardiol. 2021;78:2158-2160.
     PubMed    
     
     
     
253. RODES-CABAU J, Regueiro A, Mack MJ
     Transcatheter Mitral Valve Replacement: A Need for Better Patient Selection.
     J Am Coll Cardiol. 2021;78:1860-1862.
     PubMed    
     
     
     
254. MULLER DWM, Sorajja P, Duncan A, Bethea B, et al
     2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
     J Am Coll Cardiol. 2021;78:1847-1859.
     PubMed     Abstract available
     
     
     
255. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
     Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
     J Am Coll Cardiol. 2021;78:e159.
     PubMed    
     
     
     
256. WANG X, Wang P, Pei H
     Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
     J Am Coll Cardiol. 2021;78:e157.
     PubMed    
     
     
     
257. ARBUSTINI E, Narula N
     Aortic Smooth Muscle Detraining in Continuous Flow LVAD: Out of Practice.
     J Am Coll Cardiol. 2021;78:1796-1799.
     PubMed    
     
     
     October 2021
258. MACK M, Carroll JD, Thourani V, Vemulapalli S, et al
     Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.
     J Am Coll Cardiol. 2021 Oct 18. pii: S0735-1097(21)05852.
     PubMed     Abstract available
     
     
     September 2021
259. JEAN G, Pibarot P, Clavel MA
     Reply: Calcium Score to Specify Assessment of Low-Flow Aortic Stenosis Severity.
     J Am Coll Cardiol. 2021;78:e73.
     PubMed    
     
     
     
260. LAMM G, Auer J
     Calcium Score to Specify Assessment of Low-Flow Aortic Stenosis Severity.
     J Am Coll Cardiol. 2021;78:e71.
     PubMed    
     
     
     
261. BAUDHUIN LM
     Hypertrophic Cardiomyopathy in the General Population: Leveraging the UK Biobank Database and Machine Learning Phenotyping.
     J Am Coll Cardiol. 2021;78:1111-1113.
     PubMed    
     
     
     
262. DE MARVAO A, McGurk KA, Zheng SL, Thanaj M, et al
     Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:1097-1110.
     PubMed     Abstract available
     
     
     August 2021
263. GOMEZ JLZ, Gomez AG
     Aortic Valve Thrombosis: Be Prepared for the Unusual.
     J Am Coll Cardiol. 2021;78:825-826.
     PubMed    
     
     
     
264. ALAJAJI W, Hornick JM, Malek E, Klein AL, et al
     The Characteristics and Outcomes of Native Aortic Valve Thrombosis: A Systematic Review.
     J Am Coll Cardiol. 2021;78:811-824.
     PubMed     Abstract available
     
     
     
265. VALLE JA, Li Z, Kosinski AS, Nelson AJ, et al
     Dissemination of Transcatheter Aortic Valve Replacement in the United States.
     J Am Coll Cardiol. 2021;78:794-806.
     PubMed     Abstract available
     
     
     
266. HOLMES DR JR, Miller DC
     Rational Dispersion of TAVR: Failed Expectations and Unintended Consequences.
     J Am Coll Cardiol. 2021;78:807-810.
     PubMed    
     
     
     
267. O'SULLIVAN CJ
     Myocardial Damage and Severe Aortic Stenosis: Looking Beyond the Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2021;78:559-561.
     PubMed    
     
     
     
268. KWAK S, Everett RJ, Treibel TA, Yang S, et al
     Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.
     J Am Coll Cardiol. 2021;78:545-558.
     PubMed     Abstract available
     
     
     July 2021
269. VERMA S, Latter DA, Bonow RO
     Failed Mitral TEER: Are There Lessons for Decision Making?
     J Am Coll Cardiol. 2021;78:10-13.
     PubMed    
     
     
     
270. CHIKWE J, O'Gara P, Fremes S, Sundt TM 3rd, et al
     Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.
     J Am Coll Cardiol. 2021;78:1-9.
     PubMed     Abstract available
     
     
     June 2021
271. ALPERI A, Granada JF, Bernier M, Dagenais F, et al
     Current Status and Future Prospects of Transcatheter Mitral Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:3058-3078.
     PubMed     Abstract available
     
     
     
272. KUZEMCZAK M, Lipiecki J, Siminiak T
     Transcatheter Mitral Valve Repair: When Is the Last Moment Before Crossing the Styx River?
     J Am Coll Cardiol. 2021;77:2982.
     PubMed    
     
     
     
273. MACK MJ, Stone GW
     Reply: Transcatheter Mitral Valve Repair: When Is the Last Moment Before Crossing the Styx River?
     J Am Coll Cardiol. 2021;77:2982-2983.
     PubMed    
     
     
     
274. ELMARIAH S, Patel NK
     Aortic Stenosis and LV Dysfunction: Not Everything in Moderation.
     J Am Coll Cardiol. 2021;77:2804-2806.
     PubMed    
     
     
     
275. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
     Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;77:2796-2803.
     PubMed     Abstract available
     
     
     
276. PFALLER B, Dave Javier A, Grewal J, Gabarin N, et al
     Risk Associated With Valvular Regurgitation During Pregnancy.
     J Am Coll Cardiol. 2021;77:2656-2664.
     PubMed     Abstract available
     
     
     
277. MCANULTY J
     Heart Valve Regurgitation in Pregnancy: Risks Related to the Company It Keeps.
     J Am Coll Cardiol. 2021;77:2665-2666.
     PubMed    
     
     
     May 2021
278. CHEN J, Lv M, Hu K, Ming Y, et al
     Isolated Severe Tricuspid Regurgitation: The Unsolved Challenge.
     J Am Coll Cardiol. 2021;77:2350-2351.
     PubMed    
     
     
     
279. CANNATA A, Cantoni S, Sciortino A, Bruschi G, et al
     Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2323-2334.
     PubMed     Abstract available
     
     
     
280. NKOMO VT, DeSimone DC, Miranda WR
     Stroke Associated With Infective Endocarditis After Transcatheter Aortic Valve Replacement Is Devastating.
     J Am Coll Cardiol. 2021;77:2288-2290.
     PubMed    
     
     
     
281. DEL VAL D, Abdel-Wahab M, Mangner N, Durand E, et al
     Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2276-2287.
     PubMed     Abstract available
     
     
     
282. ALPERI A, Rodes-Cabau J, Simonato M, Tchetche D, et al
     Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry.
     J Am Coll Cardiol. 2021;77:2263-2273.
     PubMed     Abstract available
     
     
     
283. BARKER CM
     Permanent Pacemaker Implantation After TAVR for Degenerated Bioprosthetic Surgical Valves: We Could Do Better.
     J Am Coll Cardiol. 2021;77:2274-2275.
     PubMed    
     
     
     
284. FEISTRITZER HJ, Kurz T, Stachel G, Hartung P, et al
     Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2204-2215.
     PubMed     Abstract available
     
     
     
285. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
     ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2021;77:2187-2199.
     PubMed     Abstract available
     
     
     
286. CZARNY MJ, Shah SJ, Whelton SP, Blaha MJ, et al
     Race/Ethnicity and Prevalence of Aortic Stenosis by Echocardiography in the Multi-Ethnic Study of Atherosclerosis.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04964.
     PubMed    
     
     
     
287. KAPADIA SR, Krishnaswamy A
     Valve Choice in TAVR: A Complex Equation to Solve.
     J Am Coll Cardiol. 2021;77:2216-2218.
     PubMed    
     
     
     
288. GRUBERG L, Gandotra P
     STEMI Following TAVR: Unusual But Definitely Not Trivial.
     J Am Coll Cardiol. 2021;77:2200-2203.
     PubMed    
     
     
     
289. ROWIN EJ, Fifer MA
     Evaluating Histopathology to Improve Our Understanding of Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:2171-2173.
     PubMed    
     
     
     
290. CUI H, Schaff HV, Lentz Carvalho J, Nishimura RA, et al
     Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:2159-2170.
     PubMed     Abstract available
     
     
     April 2021
291. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
     Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
     J Am Coll Cardiol. 2021;77:2156-2157.
     PubMed    
     
     
     
292. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
     Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.
     J Am Coll Cardiol. 2021 Apr 15. pii: S0735-1097(21)00461.
     PubMed     Abstract available
     
     
     
293. MENTIAS A, Saad M, Desai MY, Krishnaswamy A, et al
     Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic Stenosis.
     J Am Coll Cardiol. 2021;77:1703-1713.
     PubMed     Abstract available
     
     
     March 2021
294. EL-HAMAMSY I, Warnes CA, Nishimura RA
     The Ross Procedure in Adults: The Ideal Aortic Valve Substitute?
     J Am Coll Cardiol. 2021;77:1423-1425.
     PubMed    
     
     
     
295. ABOUD A, Charitos EI, Fujita B, Stierle U, et al
     Long-Term Outcomes of Patients Undergoing the Ross Procedure.
     J Am Coll Cardiol. 2021;77:1412-1422.
     PubMed     Abstract available
     
     
     
296. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
     Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:1344-1356.
     PubMed     Abstract available
     
     
     
297. ZYRIANOV A, Spirito P, Ferrazzi P, Pezzoli L, et al
     Reply: Hypertrophic Cardiomyopathy as Congenital Heart Disease.
     J Am Coll Cardiol. 2021;77:1378-1379.
     PubMed    
     
     
     
298. MURAKAMI T, Shiraishi M
     Hypertrophic Cardiomyopathy as Congenital Heart Disease.
     J Am Coll Cardiol. 2021;77:1377-1378.
     PubMed    
     
     
     
299. PRENDERGAST BD, Redwood SR, Patterson T
     TAVR Versus SAVR in Aortic Stenosis: Long Journey, New Roadmap.
     J Am Coll Cardiol. 2021;77:1162-1164.
     PubMed    
     
     
     
300. LEON MB, Mack MJ, Hahn RT, Thourani VH, et al
     Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.
     J Am Coll Cardiol. 2021;77:1149-1161.
     PubMed     Abstract available
     
     
     
301. MUSUMECI MB, Spirito P, Conte MR, Lillo R, et al
     Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2021;77:1262-1264.
     PubMed    
     
     
     
302. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
     3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1029-1040.
     PubMed     Abstract available
     
     
     
303. DEPTA JP, Bhatt DL
     Crossover in COAPT: Does This Extend the Reach of TMVr for Treating Functional MR?
     J Am Coll Cardiol. 2021;77:1041-1043.
     PubMed    
     
     
     February 2021
304. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
     Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2021;77:713-724.
     PubMed     Abstract available
     
     
     
305. TERNACLE J, Pibarot P, Hahn RT
     Reply: TAVR Versus SAVR or Valve Versus Valve?
     J Am Coll Cardiol. 2021;77:833-834.
     PubMed    
     
     
     
306. USEINI D
     TAVR Versus SAVR or Valve Versus Valve?
     J Am Coll Cardiol. 2021;77:832-833.
     PubMed    
     
     
     
307. MICK SL
     The Tricuspid Valve: No Longer Forgotten But Still Not Well Understood.
     J Am Coll Cardiol. 2021;77:725-727.
     PubMed    
     
     
     
308. PARK SJ, Lee S, Lee SA, Kim DH, et al
     Impact of Early Surgery and Staging Classification on Survival in Asymptomatic Very Severe Aortic Stenosis.
     J Am Coll Cardiol. 2021;77:506-508.
     PubMed    
     
     
     
309. ASGAR AW
     Transcatheter Tricuspid Valve Therapy: Zeroing in on the Target.
     J Am Coll Cardiol. 2021;77:357-359.
     PubMed    
     
     
     
310. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
     Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:345-356.
     PubMed     Abstract available
     
     
     January 2021
311. DONAL E, Leurent G, Iung B
     Are We Right to Believe in the Value of Transcatheter Treatment of Secondary Tricuspid Regurgitation?
     J Am Coll Cardiol. 2021;77:240-242.
     PubMed    
     
     
     
312. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
     Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
     J Am Coll Cardiol. 2021;77:229-239.
     PubMed     Abstract available
     
     
     
313. ALPERI A, Voisine P, Kalavrouziotis D, Dumont E, et al
     Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis Outside Randomized Trials.
     J Am Coll Cardiol. 2021;77:111-123.
     PubMed     Abstract available
     
     
     
314. VELAGAPUDI P, Bapat V, Kodali S
     When Excluded From Randomized Clinical Trials: To "OR" or "'TAVR"?
     J Am Coll Cardiol. 2021;77:124-127.
     PubMed    
     
     
     
315. LANDES U, Sathananthan J, Witberg G, De Backer O, et al
     Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses.
     J Am Coll Cardiol. 2021;77:1-14.
     PubMed     Abstract available
     
     
     
316. MORRAY BH, McElhinney DB
     Semilunar Valve Interventions for Congenital Heart Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:71-79.
     PubMed     Abstract available
     
     
     December 2020
317. EL-ESHMAWI A, Pandis D, Miller MA, Boateng P, et al
     Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.
     J Am Coll Cardiol. 2020;76:3061-3062.
     PubMed    
     
     
     
318. KLEIN AL, Ramchand J, Nagueh SF
     Aortic Stenosis and Diastolic Dysfunction: Partners in Crime.
     J Am Coll Cardiol. 2020;76:2952-2955.
     PubMed    
     
     
     
319. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
     Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
     J Am Coll Cardiol. 2020;76:2940-2951.
     PubMed     Abstract available
     
     
     
320. EGBE AC, Miranda WR, Dearani J, Kamath PS, et al
     Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.
     J Am Coll Cardiol. 2020;76:2968-2976.
     PubMed     Abstract available
     
     
     
321. OMMEN SR, Mital S, Burke MA, Day SM, et al
     2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020;76:e159-e240.
     PubMed    
     
     
     
322. OMMEN SR, Mital S, Burke MA, Day SM, et al
     2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020;76:3022-3055.
     PubMed     Abstract available
     
     
     
323. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
     2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020 Dec 17. pii: S0735-1097(20)37796.
     PubMed    
     
     
     
324. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
     2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2020 Dec 10. pii: S0735-1097(20)37902.
     PubMed     Abstract available
     
     
     
325. PAPATHEODOROU E, Anastasakis A
     Arrhythmic Mitral Valve Prolapse: Implications for Family Screening and Sports Participation Eligibility.
     J Am Coll Cardiol. 2020;76:2691.
     PubMed    
     
     
     
326. ESSAYAGH B, Sabbag A, Benfari G, Enriquez-Sarano M, et al
     Reply: The Arrhythmic Mitral Valve Prolapse: The Questions and the Way Forward.
     J Am Coll Cardiol. 2020;76:2691-2693.
     PubMed    
     
     
     
327. MUTHUKUMAR L, Jan MF, Jahangir A, Tajik AJ, et al
     On Arrhythmic Mitral Valve Prolapse: The Devil Is in the Details.
     J Am Coll Cardiol. 2020;76:2690.
     PubMed    
     
     
     
328. HAN HC, Teh AW, Hare DL, Farouque O, et al
     The Clinical Demographics of Arrhythmic Mitral Valve Prolapse.
     J Am Coll Cardiol. 2020;76:2689-2690.
     PubMed    
     
     
     
329. ALQARAWI W, Cheung CC, Davies B, Krahn AD, et al
     Arrhythmic Mitral Valve Prolapse: Looking for a Needle in a Haystack.
     J Am Coll Cardiol. 2020;76:2688-2689.
     PubMed    
     
     
     
330. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
     Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:2595-2606.
     PubMed     Abstract available
     
     
     
331. RADERMECKER MA, Sprynger M, Hans G
     TAVR for Stenotic Bicuspid Aortic Valve: Feasible, Continuously Improving Results With Another Red Flag.
     J Am Coll Cardiol. 2020;76:2591-2594.
     PubMed    
     
     
     
332. FAN J, Fang X, Liu C, Zhu G, et al
     Brain Injury After Transcatheter Replacement of Bicuspid Versus Tricuspid Aortic Valves.
     J Am Coll Cardiol. 2020;76:2579-2590.
     PubMed     Abstract available
     
     
     
333. OPOTOWSKY AR, Dimopoulos K, Buber J
     Implications of Elevated Pulmonary Artery Pressure for Transcatheter Mitral Repair: Time for Comprehensive Hemodynamic Investigation.
     J Am Coll Cardiol. 2020;76:2607-2610.
     PubMed    
     
     
     
334. ALKHOULI M, Alqahtani F, Kawsara A, Pislaru S, et al
     National Trends in Mechanical Valve Replacement in Patients Aged 50 to 70 Years.
     J Am Coll Cardiol. 2020;76:2687-2688.
     PubMed    
     
     
     November 2020
335. MENTIAS A, Desai MY, Saad M, Rossen J, et al
     Transcatheter Aortic Valve Replacement in Kidney Transplant Patients.
     J Am Coll Cardiol. 2020;76:2571-2573.
     PubMed    
     
     
     
336. CARROLL JD, Mack MJ, Vemulapalli S, Herrmann HC, et al
     STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;76:2492-2516.
     PubMed     Abstract available
     
     
     
337. DANGAS GD, Adams DH
     Noncontrast Nephropathy After Percutaneous Mitral Valve Edge-to-Edge Repair.
     J Am Coll Cardiol. 2020;76:2474-2476.
     PubMed    
     
     
     
338. ARMIJO G, Estevez-Loureiro R, Carrasco-Chinchilla F, Arzamendi D, et al
     Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair.
     J Am Coll Cardiol. 2020;76:2463-2473.
     PubMed     Abstract available
     
     
     
339. LILLY SM, Deshmukh AJ, Epstein AE, Ricciardi MJ, et al
     2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2020;76:2391-2411.
     PubMed     Abstract available
     
     
     
340. MORI M, Gan G, Bin Mahmood SU, Deng Y, et al
     Variations in Anticoagulation Practice Following Bioprosthetic Aortic and Mitral Valve Replacement and Repair.
     J Am Coll Cardiol. 2020;76:2412-2413.
     PubMed    
     
     
     
341. SHERRID MV, Adams DH
     The Mitral Valve in Hypertrophic Cardiomyopathy: Other Side of the Outflow Tract.
     J Am Coll Cardiol. 2020;76:2248-2251.
     PubMed    
     
     
     
342. FERRAZZI P, Spirito P, Binaco I, Zyrianov A, et al
     Congenital Muscular Mitral-Aortic Discontinuity Identified in Patients With Obstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;76:2238-2247.
     PubMed     Abstract available
     
     
     
343. ZAIDI AN, Adams DH
     Risk Assessment in Patients with Tricuspid Valve Regurgitation: MELD and Beyond.
     J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37755.
     PubMed    
     
     
     
344. PIBAROT P, Lancellotti P, Narula J
     Concomitant Cardiac Amyloidois in Severe Aortic Stenosis: The Trojan Horse?
     J Am Coll Cardiol. 2020 Nov 6. pii: S0735-1097(20)37752.
     PubMed    
     
     
     
345. NITSCHE C, Scully PR, Patel KP, Kammerlander A, et al
     Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
     J Am Coll Cardiol. 2020 Nov 5. pii: S0735-1097(20)37735.
     PubMed     Abstract available
     
     
     
346. YANG LT, Daniels BK, Enriquez-Sarano M, Michelena HI, et al
     Reply: Beyond the Valve, Left Ventricle Remodeling May Be the Pivotal Factor for Survival in AR.
     J Am Coll Cardiol. 2020;76:2177-2179.
     PubMed    
     
     
     
347. JIANG X, Liu J, Gu T
     Beyond the Valve, Left Ventricle Remodeling May Be the Pivotal Factor for Survival in AR.
     J Am Coll Cardiol. 2020;76:2177.
     PubMed    
     
     
     October 2020
348. GUZZETTI E, Poulin A, Annabi MS, Kalavrouziotis D, et al
     Pre- and Post-Operative Stroke Volume Impact After Surgical Aortic Valve Replacement for Severe Aortic Stenosis.
     J Am Coll Cardiol. 2020;76:2036-2038.
     PubMed    
     
     
     
349. JAWITZ OK
     Surgical Aortic Valve Replacement for Failed TAVR Prostheses: One More Piece of the Puzzle.
     J Am Coll Cardiol. 2020;76:1860-1861.
     PubMed    
     
     
     
350. HIRJI SA, Percy ED, McGurk S, Malarczyk A, et al
     Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement.
     J Am Coll Cardiol. 2020;76:1848-1859.
     PubMed     Abstract available
     
     
     
351. PIBAROT P, Ternacle J, Jaber WA, Salaun E, et al
     Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
     J Am Coll Cardiol. 2020;76:1830-1843.
     PubMed     Abstract available
     
     
     
352. VAN BELLE E, Delhaye C, Vincent F
     Structural Valve Deterioration at 5 Years of TAVR Versus SAVR: Half Full or Half Empty?
     J Am Coll Cardiol. 2020;76:1844-1847.
     PubMed    
     
     
     
353. ZHANG B, Salaun E, Cote N, Wu Y, et al
     Association of Bioprosthetic Aortic Valve Leaflet Calcification on Hemodynamic and Clinical Outcomes.
     J Am Coll Cardiol. 2020;76:1737-1748.
     PubMed     Abstract available
     
     
     
354. BORER JS
     Bioprosthesis Failure: Is Calcification the Only Problem?
     J Am Coll Cardiol. 2020;76:1749-1750.
     PubMed    
     
     
     September 2020
355. BURATTO E, Wallace FRO, Fricke TA, Brink J, et al
     Ross Procedures in Children With Previous Aortic Valve Surgery.
     J Am Coll Cardiol. 2020;76:1564-1573.
     PubMed     Abstract available
     
     
     
356. EL-HAMAMSY I, Stelzer P, Adams DH
     The Ross Procedure in Children Undergoing Reintervention: Another Victory for Nonthrombogenic Surgery.
     J Am Coll Cardiol. 2020;76:1574-1576.
     PubMed    
     
     
     
357. GALPER BZ, Goldsweig AM, Bhatt DL
     TAVR and the Kidney: Is This the Beginning of a Beautiful Friendship?
     J Am Coll Cardiol. 2020;76:1422-1424.
     PubMed    
     
     
     
358. ANWARUDDIN S, Desai N
     Systematic Approach Toward Transcatheter Treatment of BAV Disease: One Size Does Not Fit All.
     J Am Coll Cardiol. 2020;76:1031-1033.
     PubMed    
     
     
     
359. HAHN RT
     Super-Responders and Nonresponders in the COAPT Trial: Not as Simple as Clip or No Clip.
     J Am Coll Cardiol. 2020;76:1015-1017.
     PubMed    
     
     
     August 2020
360. KAUL S
     Raising the Evidentiary Bar for Guideline Recommendations for TAVR: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:985-991.
     PubMed     Abstract available
     
     
     
361. ROWIN EJ, Maron BJ, Maron MS
     The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36310.
     PubMed    
     
     
     
362. DALZELL JR, Connolly EC, Cannon JA
     The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy.
     J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36312.
     PubMed    
     
     
     
363. SEMSARIAN C, Semsarian CR
     Variable Penetrance in Hypertrophic Cardiomyopathy: In Search of the Holy Grail.
     J Am Coll Cardiol. 2020;76:560-562.
     PubMed    
     
     
     
364. LORENZINI M, Norrish G, Field E, Ochoa JP, et al
     Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
     J Am Coll Cardiol. 2020;76:550-559.
     PubMed     Abstract available
     
     
     July 2020
365. KOCHILAS L
     Atrioventricular Valve Regurgitation in the Single Ventricle: Back to Hippocrates.
     J Am Coll Cardiol. 2020;76:432-434.
     PubMed    
     
     
     
366. MOON J, Shen L, Likosky DS, Sood V, et al
     Relationship of Ventricular Morphology and Atrioventricular Valve Function to Long-Term Outcomes Following Fontan Procedures.
     J Am Coll Cardiol. 2020;76:419-431.
     PubMed     Abstract available
     
     
     June 2020
367. BRINKLEY DM, Wells QS, Stevenson LW
     Avoiding Burnout From Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;75:3044-3047.
     PubMed    
     
     
     
368. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
     Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
     J Am Coll Cardiol. 2020;75:3033-3043.
     PubMed     Abstract available
     
     
     
369. MAKKAR RR, Blanke P, Leipsic J, Thourani V, et al
     Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.
     J Am Coll Cardiol. 2020;75:3003-3015.
     PubMed     Abstract available
     
     
     
370. WILCOX JE, McNally EM
     Lessons From MAVERICK-HCM: The Need for Less Speed.
     J Am Coll Cardiol. 2020;75:2661-2663.
     PubMed    
     
     
     
371. HO CY, Mealiffe ME, Bach RG, Bhattacharya M, et al
     Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.
     J Am Coll Cardiol. 2020;75:2649-2660.
     PubMed     Abstract available
     
     
     May 2020
372. ALOIA E
     Resting Heart Rate and Diastolic Blood Pressure in AR: Still a Matter of Debate.
     J Am Coll Cardiol. 2020;75:2276.
     PubMed    
     
     
     
373. JIANG X, Zhang Y, Gu T
     Cardiac Output and Blood Supply of Cardiomyocytes May Be Determinants of Clinical Outcomes in AR.
     J Am Coll Cardiol. 2020;75:2275-2276.
     PubMed    
     
     
     
374. MEINERTZ T, Munzel T
     Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
     J Am Coll Cardiol. 2020;75:2107-2109.
     PubMed    
     
     
     April 2020
375. MEHMOOD M
     Echocardiographic Outcomes in the COAPT Trial: Asking the "Right" Question.
     J Am Coll Cardiol. 2020;75:2095.
     PubMed    
     
     
     
376. THOURANI VH, Edelman JJ, Meduri CU
     TAVR in TAVR: The Future Is Now.
     J Am Coll Cardiol. 2020;75:1894-1896.
     PubMed    
     
     
     
377. BERGLER-KLEIN J
     NT-proBNP as a Cornerstone for Prognosis in Valve Disease: All We Need Is Blood.
     J Am Coll Cardiol. 2020;75:1673-1675.
     PubMed    
     
     
     March 2020
378. KHAN JM, Rogers T, Greenbaum AB, Babaliaros VC, et al
     Transcatheter Electrosurgery: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2020;75:1455-1470.
     PubMed     Abstract available
     
     
     
379. DIMITROW PP, Rajtar-Salwa R
     Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study.
     J Am Coll Cardiol. 2020;75:1242.
     PubMed    
     
     
     
380. KRAMER CM, Neubauer S
     Reply: Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study.
     J Am Coll Cardiol. 2020;75:1242-1243.
     PubMed    
     
     
     
381. COYLEWRIGHT M, Forrest JK, McCabe JM, Nazif TM, et al
     TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making.
     J Am Coll Cardiol. 2020;75:1208-1211.
     PubMed    
     
     
     
382. DESHAIES C, Trottier H, Khairy P, Al-Aklabi M, et al
     Tricuspid Intervention Following Pulmonary Valve Replacement in Adults With Congenital Heart Disease.
     J Am Coll Cardiol. 2020;75:1033-1043.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.